Open AccessMechanism-based heparanase inhibitors reduce cancer metastasis in vivo
Author(s) -
Casper de Boer,
Zachary Armstrong,
Vincent A J Lit,
Uri Barash,
Gijs Ruijgrok,
Ilanit Boyango,
Merle M Weitzenberg,
Sybrin P. Schröder,
Alexi J C Sarris,
Nico J. Meeuwenoord,
Pedro Bule,
Yasmine Kayal,
Neta Ilan,
Jeroen D. C. Codée,
Israël Vlodavsky,
Herman S. Overkleeft,
G.J. Davies,
Liang Wu
Publication year - 2022
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2203167119
Subject(s) - heparanase , extracellular matrix , metastasis , heparan sulfate , cancer cell , glycosaminoglycan , cancer , carcinogenesis , cancer research , microbiology and biotechnology , extracellular , chemistry , biology , biochemistry , genetics